Marc Lefebvre

Vice President, Scientific & Regulatory Affairs
Algorithme Pharma Inc.

Dr. Marc Lefebvre is the co-founder and the Vice President, Scientific & Regulatory Affairs at Algorithme Pharma, a Contract Research Organization (CRO) involved in the conduct of Early Stage Clinical Trials (Phase I/IIa) in humans. He leads scientific, regulatory and pharmacological decisions on every clinical trial conducted at the organization.

With more than 25 years of experience in pharmacology, pharmacokinetics and clinical trials, including few years worked at Schering Canada (1987), Marion Merrell Dow Canada (1994) and Glaxo-Wellcome (1995), Dr. Lefebvre had always interests in the development of new drugs and formulations (Phase I/IIa). He also gave frequent lecturing at symposiums and workshops on the conduct of Phase I Clinical Trials and as an invited professor at the Université de Montreal. Following his bachelor degree in Pharmacy, he completed his M.Sc. and Ph.D. degrees in Pharmacology (Faculty of Medicine) at the Université de Montreal. He has published more than 35 abstracts and 21 papers on related topics.